The Cass Review in England found that medical evidence for gender care for adolescents is weak, leading to a lack of clarity on long-term outcomes. The report emphasizes the need for better care for young people with gender dysphoria but highlights the lack of good evidence on how to provide it.
Key Points
Medical evidence for gender care for adolescents in England is weak
The report stresses the need for better care for young people with gender dysphoria
Extreme caution is recommended around providing hormones before the age of 18
Pros
Emphasizes the need for better care for young people with gender dysphoria
Urges extreme caution around providing hormones before the age of 18
Cons
Medical evidence underlying gender care for adolescents is weak